brimonidine tartrate during pregnancy

Перейти к контенту

Главное меню:

brimonidine tartrate during pregnancy
Brimonidine ophthalmic Use During Pregnancy |, BRIMONIDINE TARTRATE | Drug | BNF content published by NICE, Brimonidine Tartrate 0.2% w/v Eye Drops. - Summary of , Alphagan and Pregnancy - Glaucoma Home Page, Brinzolamide + Brimonidine Tartrate | Indications , Alphagan (Brimonidine Tartrate) -, Brimonidine TARTRATE Drops -, Brimonidine Tartrate Ophthalmic Solution 0.2% (Sterile), Alphagan-P (Brimonidine Tartrate): Side Effects .
Animal studies have revealed maternotoxicity and increased early resorptions/post-implantation losses and decreased pup viability and bodyweights at exposures. Additional animal studies have shown that this drug crossed the placenta and entered into the fetal circulation to a limited extent. There are no adequate and well-controlled studies in pregnant women.AU TGA pregnancy category B3: Drugs which have been taken by only a limited number of pregnant women and women of childbearing age, without an increase in the frequency of malformation or other direct or indirect harmful effects on the human fetus having been observed. Studies in animals have shown evidence of an increased occurrence of fetal damage, the significance of which is considered uncertain in humans.US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.. Brimonidine ophthalmic Pregnancy Warnings This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus. AU TGA pregnancy category: B3. Symptom exacerbation has been reported very commonly in patients treated with brimonidine gel. Treatment should be initiated with a small amount of gel (less than the maximum dose) for at least 1 week, then increased gradually, based on tolerability and response..
In rabbits, brimonidine tartrate at plasma levels higher than are achieved during therapy in humans, has been shown to cause increased preimplantation loss and postnatal growth reduction. Brimonidine eye drops should only be used during pregnancy if the potential benefit to the mother outweighs the potential risk to the foetus.. Alphagan ® (brimonidine tartrate) is an eye medication approved for the treatment of high eye pressure and open-angle glaucoma. Based on the results of animal studies, Alphagan appears to be relatively safe for use during pregnancy, although the full risks to humans are currently unknown.. Pregnancy category C. There are no adequate and well-controlled studies in pregnant women. Brinzolamide and Brimonidine Tartrate ophthalmic suspension should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.. Brimonidine should be used during pregnancy only if the potential benefit to the mother justifies the potential risk to the fetus. Lactation : It is not known whether brimonidine is excreted in human milk; although in animal studies, brimonidine has been shown to be excreted in breast milk.. How to use Brimonidine TARTRATE Drops. To apply eye drops, wash your hands first. To avoid contamination, do not touch the dropper tip or let it touch your eye or any other surface.. Brimonidine tartrate ophthalmic solution should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud’s phenomenon, orthostatic hypotension or thromboangiitis obliterans. During the studies there was a loss of effect in some patients. The IOP-lowering efficacy observed with brimonidine tartrate ophthalmic solution during the first month of therapy may .
Copyright 2019. All rights reserved.
Назад к содержимому | Назад к главному меню